September 23, 2025

GRAIL, Inc. (GRAL) Investor Outlook: A Healthcare Innovator with a $1.6 Billion Market Cap

GRAIL, Inc. (GRAL), a pioneering force in the healthcare sector, is making waves with its advanced diagnostics and research solutions. Headquartered in Menlo Park, California, this..

HUTCHMED (China) Limited (HCM) Stock Analysis: A 35.31% Upside Potential Amidst Healthcare Innovations

HUTCHMED (China) Limited (NASDAQ: HCM) is carving a niche in the global healthcare sector, focusing on the discovery and commercialization of targeted therapeutics and immunotherapies. Despite..

Janux Therapeutics, Inc. (JANX): Investor Outlook on a Biotech with a 234% Potential Upside

As investors navigate the complex landscape of biotechnology stocks, Janux Therapeutics, Inc. (NASDAQ: JANX) emerges as a compelling candidate for those seeking high-growth potential. With its..

Kestra Medical Technologies (KMTS) Stock Analysis: Impressive Revenue Growth with Significant Upside Potential

Investors eyeing the healthcare sector should pay close attention to Kestra Medical Technologies, Ltd. (KMTS), a dynamic player in the medical instruments and supplies industry. With..

Surgery Partners, Inc. (SGRY): Investor Outlook on a Potential 40.92% Upside

Surgery Partners, Inc. (NASDAQ: SGRY) has positioned itself as a significant player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Brentwood,..

NeoGenomics, Inc. (NEO) Stock Analysis: Uncovering a Potential 19% Upside in the Diagnostics Sector

NeoGenomics, Inc. (NEO), a prominent player in the healthcare sector, has carved a niche in the diagnostics and research industry with its specialized cancer-focused testing laboratories...

Integra LifeSciences Holdings (IART) Stock Analysis: A Deep Dive into its 10.17% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, operates within the specialized industry of medical devices. Headquartered in Princeton, New Jersey,..

10x Genomics, Inc. (TXG) Stock Analysis: Unpacking a 15.58% Potential Upside for Investors

Investors with a keen eye on the healthcare sector might find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing prospect. With its specialized focus on health information..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating the CNS Drug Maker’s Market Position and Growth Potential

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a notable player in the healthcare sector specializing in drug manufacturing for central nervous system (CNS) diseases, has been capturing investor..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a Potential 88% Upside in the Biotech Space

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneer in the field of biotechnology, is capturing investor attention with its innovative approach to precision genetic medicines. Headquartered in..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Leading Biotech with an 8.75% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to developing peptide therapeutics for complex..

Privia Health Group, Inc. (PRVA): Investor Outlook Reveals 32% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA), a noted player in the healthcare sector, is drawing significant investor attention with its promising growth prospects and strategic positioning..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Analyst Consensus Pointing to a 23.81% Upside

BioLife Solutions, Inc. (NASDAQ: BLFS) operates at the fascinating intersection of healthcare and technology, specifically within the medical instruments and supplies industry. With a market capitalization..

Brookdale Senior Living Inc. (BKD): Investor Outlook Amidst Strong Revenue Growth and Challenging Valuations

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specializes in providing senior living communities across the United States. Despite its extensive..

Novavax, Inc. (NVAX) Stock Analysis: Assessing a 40.92% Potential Upside in the Biotech Sector

Investors keen on exploring opportunities in the biotechnology sector should consider Novavax, Inc. (NASDAQ: NVAX), a company renowned for its innovative vaccine technologies. Headquartered in Gaithersburg,..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring Upside Potential with a 16.80% Revenue Growth

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) presents an intriguing opportunity for investors interested in the healthcare sector, particularly within the medical care facilities industry. This Atlanta-based..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Unpacking a 47% Upside Potential

Investors with an eye for growth opportunities in the biotech sector might find Xenon Pharmaceuticals Inc. (NASDAQ: XENE) an intriguing prospect. With a market cap of..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 25% Potential Upside Awaits Investors

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, is garnering attention from investors with a tantalizing 25% potential upside. As a global biopharmaceutical..

89bio, Inc. (ETNB) Stock Analysis: Exploring a 125% Potential Upside in Clinical-Stage Biotech

89bio, Inc. (NASDAQ: ETNB) is capturing the attention of investors with its promising pipeline in the biotechnology sector. This clinical-stage biopharmaceutical company, established in 2018 and..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unpacking a 282% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX), a key player in the biotechnology sector, is garnering considerable attention from investors due to its robust growth potential and promising therapeutic..

Search

Funds

September 23, 2025

Search

Funds

September 23, 2025

FTSE 100

Funds